This grant is for supporting collaborative, multi-disciplinary research projects aimed at addressing critical and inadequately explored questions in breast cancer. The DoD Breast Cancer Multi-Team Award encourages the creation of three-team collaborations, each led by a Principal Investigator (a basic scientist, a clinician, and another expert). A key requirement is the integral involvement of breast cancer consumer advocates throughout the project, from design to evaluation. The grant emphasizes fostering innovation, creativity, and intensive cross-disciplinary interaction, including regular in-person meetings and cross-training opportunities. Proposed research must include clinical studies and offer broad implications for disease and risk management, transforming the research process through integrated basic and clinical disciplines.
Opportunity ID: 51452
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-MTA |
| Funding Opportunity Title: | DoD Breast Cancer Multi-Team Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 29, 2010 |
| Last Updated Date: | Feb 01, 2010 |
| Original Closing Date for Applications: | Jun 23, 2010 |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $23,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The BCRP Multi-Team Award supports the creation of a collaborative research project among three teams, each led by a Principal Investigator (PI) with a history of creativity and innovation, to focus on a critical area of breast cancer. The Multi-Team Award should create an environment that fosters and supports innovation and creativity, with consistent, intensive interaction across teams in a way that engages all members of the teams in all aspects of the research project. The multi-team approach is expected to transform the research process through the integration of basic and clinical disciplines, substantive cross-disciplinary training among the scientists on the teams, and integral participation of consumer advocates. The requirements for this award are as follows: Research Question: Research proposed under the Multi-Team Award must focus on a question of significant importance to breast cancer that has been inadequately addressed, or for which there may be an absence of an established paradigm or technical framework. The research question should address overarching issues that have broad implications for the disease and risk management (e.g., risk factors, dormancy) and not focus merely on the study of specific pathways or genes. Clinical research (may include clinical trials) must be included as part of the proposed work. Teams of Scientists and Consumers: The Multi-Team Award supports the collaborative efforts of three teams consisting of scientists and consumer advocates. PIs: The three PIs, one for each team, must include one basic scientist, one clinician, and one additional individual from any appropriate area of expertise (e.g., epidemiology). At least two different institutions must be represented by the three PIs. Each of the three PIs is expected to have a track record of innovation and creativity, and be well qualified to lead his/her respective team in this intensive collaboration. The collaborating PIs should work together to develop the research plan, determine the management structure, and prepare the application. It should be clear that all PIs have an equal level of intellectual input into the proposed project. Collectively, the members of the teams should represent the appropriate DOD FY10 Breast Cancer Multi-Team Award 3 diversity of expertise necessary for addressing the research question. Effort is expected to be balanced among the three teams, unless otherwise justified. Consumer Advocates: Each PIs team must include one or more breast cancer consumer advocates who will be integrally involved throughout the planning and implementation of the research project and management of the collaboration. Consumer advocates should be involved in the identification of the research question, project design, oversight, recruitment, and evaluation, in addition to other areas. Interactions with the research team members should be well-integrated and ongoing, not limited to attending seminars and semi-annual meetings. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer, they should be involved with a breast cancer advocacy organization, and their role in the project should be independent of their employment. They should not be employees of any of the organizations applying for the grant. Regardless of their professional credentials, they should have a high level of training and familiarity with current issues in breast cancer research. Team Interaction and Training: Regular in-person meetings and cross-training among members of all three teams are requirements of this award. The in-person multi-team meetings are intended to assess research progress, address problems, and define future directions. These meetings must take place at least twice a year and must be attended by all three PIs and key research team members (including consumer advocates). It is also expected that frequent (e.g., weekly) meetings of all team members will occur using phone conference/webcast communications technology to share data and monitor progress toward specific aims. A server should be established that makes team member presentations and source data available to all team members. To provide immersive training and interaction across disciplines, at least two key members of each research team must dedicate time to working on the funded research in another collaborating teams laboratory or clinic. This cross-training may be accomplished through one extensive visit of several weeks or through several separate visits. The PIs must present a clear plan for how they would manage and facilitate meaningful collaboration among the separate research teams to enable successful completion of the proposed research. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The proposal should include an organizational chart identifying the roles of all team members and the workflow within and between labs. The required Statement of Work (SOW) should indicate specific milestones, and how specific aims toward these milestones will be staged or integrated. Key decision points in the organizational/work flow chart and SOW should be clearly defined, and their impact on the overall project should be clear. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of this modification is to incorporatte the application instructions into this announcement. No changes were made to the Program Announcement. | Feb 01, 2010 | |
| Feb 01, 2010 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-MTA |
| Funding Opportunity Title: | DoD Breast Cancer Multi-Team Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 29, 2010 |
| Last Updated Date: | Feb 01, 2010 |
| Original Closing Date for Applications: | Jun 23, 2010 |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $23,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The BCRP Multi-Team Award supports the creation of a collaborative research project among three teams, each led by a Principal Investigator (PI) with a history of creativity and innovation, to focus on a critical area of breast cancer. The Multi-Team Award should create an environment that fosters and supports innovation and creativity, with consistent, intensive interaction across teams in a way that engages all members of the teams in all aspects of the research project. The multi-team approach is expected to transform the research process through the integration of basic and clinical disciplines, substantive cross-disciplinary training among the scientists on the teams, and integral participation of consumer advocates. The requirements for this award are as follows: Research Question: Research proposed under the Multi-Team Award must focus on a question of significant importance to breast cancer that has been inadequately addressed, or for which there may be an absence of an established paradigm or technical framework. The research question should address overarching issues that have broad implications for the disease and risk management (e.g., risk factors, dormancy) and not focus merely on the study of specific pathways or genes. Clinical research (may include clinical trials) must be included as part of the proposed work. Teams of Scientists and Consumers: The Multi-Team Award supports the collaborative efforts of three teams consisting of scientists and consumer advocates. PIs: The three PIs, one for each team, must include one basic scientist, one clinician, and one additional individual from any appropriate area of expertise (e.g., epidemiology). At least two different institutions must be represented by the three PIs. Each of the three PIs is expected to have a track record of innovation and creativity, and be well qualified to lead his/her respective team in this intensive collaboration. The collaborating PIs should work together to develop the research plan, determine the management structure, and prepare the application. It should be clear that all PIs have an equal level of intellectual input into the proposed project. Collectively, the members of the teams should represent the appropriate DOD FY10 Breast Cancer Multi-Team Award 3 diversity of expertise necessary for addressing the research question. Effort is expected to be balanced among the three teams, unless otherwise justified. Consumer Advocates: Each PIs team must include one or more breast cancer consumer advocates who will be integrally involved throughout the planning and implementation of the research project and management of the collaboration. Consumer advocates should be involved in the identification of the research question, project design, oversight, recruitment, and evaluation, in addition to other areas. Interactions with the research team members should be well-integrated and ongoing, not limited to attending seminars and semi-annual meetings. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer, they should be involved with a breast cancer advocacy organization, and their role in the project should be independent of their employment. They should not be employees of any of the organizations applying for the grant. Regardless of their professional credentials, they should have a high level of training and familiarity with current issues in breast cancer research. Team Interaction and Training: Regular in-person meetings and cross-training among members of all three teams are requirements of this award. The in-person multi-team meetings are intended to assess research progress, address problems, and define future directions. These meetings must take place at least twice a year and must be attended by all three PIs and key research team members (including consumer advocates). It is also expected that frequent (e.g., weekly) meetings of all team members will occur using phone conference/webcast communications technology to share data and monitor progress toward specific aims. A server should be established that makes team member presentations and source data available to all team members. To provide immersive training and interaction across disciplines, at least two key members of each research team must dedicate time to working on the funded research in another collaborating teams laboratory or clinic. This cross-training may be accomplished through one extensive visit of several weeks or through several separate visits. The PIs must present a clear plan for how they would manage and facilitate meaningful collaboration among the separate research teams to enable successful completion of the proposed research. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The proposal should include an organizational chart identifying the roles of all team members and the workflow within and between labs. The required Statement of Work (SOW) should indicate specific milestones, and how specific aims toward these milestones will be staged or integrated. Key decision points in the organizational/work flow chart and SOW should be clearly defined, and their impact on the overall project should be clear. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-MTA |
| Funding Opportunity Title: | DoD Breast Cancer Multi-Team Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 01, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $23,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The BCRP Multi-Team Award supports the creation of a collaborative research project among three teams, each led by a Principal Investigator (PI) with a history of creativity and innovation, to focus on a critical area of breast cancer. The Multi-Team Award should create an environment that fosters and supports innovation and creativity, with consistent, intensive interaction across teams in a way that engages all members of the teams in all aspects of the research project. The multi-team approach is expected to transform the research process through the integration of basic and clinical disciplines, substantive cross-disciplinary training among the scientists on the teams, and integral participation of consumer advocates. The requirements for this award are as follows: Research Question: Research proposed under the Multi-Team Award must focus on a question of significant importance to breast cancer that has been inadequately addressed, or for which there may be an absence of an established paradigm or technical framework. The research question should address overarching issues that have broad implications for the disease and risk management (e.g., risk factors, dormancy) and not focus merely on the study of specific pathways or genes. Clinical research (may include clinical trials) must be included as part of the proposed work. Teams of Scientists and Consumers: The Multi-Team Award supports the collaborative efforts of three teams consisting of scientists and consumer advocates. PIs: The three PIs, one for each team, must include one basic scientist, one clinician, and one additional individual from any appropriate area of expertise (e.g., epidemiology). At least two different institutions must be represented by the three PIs. Each of the three PIs is expected to have a track record of innovation and creativity, and be well qualified to lead his/her respective team in this intensive collaboration. The collaborating PIs should work together to develop the research plan, determine the management structure, and prepare the application. It should be clear that all PIs have an equal level of intellectual input into the proposed project. Collectively, the members of the teams should represent the appropriate DOD FY10 Breast Cancer Multi-Team Award 3 diversity of expertise necessary for addressing the research question. Effort is expected to be balanced among the three teams, unless otherwise justified. Consumer Advocates: Each PIs team must include one or more breast cancer consumer advocates who will be integrally involved throughout the planning and implementation of the research project and management of the collaboration. Consumer advocates should be involved in the identification of the research question, project design, oversight, recruitment, and evaluation, in addition to other areas. Interactions with the research team members should be well-integrated and ongoing, not limited to attending seminars and semi-annual meetings. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer, they should be involved with a breast cancer advocacy organization, and their role in the project should be independent of their employment. They should not be employees of any of the organizations applying for the grant. Regardless of their professional credentials, they should have a high level of training and familiarity with current issues in breast cancer research. Team Interaction and Training: Regular in-person meetings and cross-training among members of all three teams are requirements of this award. The in-person multi-team meetings are intended to assess research progress, address problems, and define future directions. These meetings must take place at least twice a year and must be attended by all three PIs and key research team members (including consumer advocates). It is also expected that frequent (e.g., weekly) meetings of all team members will occur using phone conference/webcast communications technology to share data and monitor progress toward specific aims. A server should be established that makes team member presentations and source data available to all team members. To provide immersive training and interaction across disciplines, at least two key members of each research team must dedicate time to working on the funded research in another collaborating teams laboratory or clinic. This cross-training may be accomplished through one extensive visit of several weeks or through several separate visits. The PIs must present a clear plan for how they would manage and facilitate meaningful collaboration among the separate research teams to enable successful completion of the proposed research. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The proposal should include an organizational chart identifying the roles of all team members and the workflow within and between labs. The required Statement of Work (SOW) should indicate specific milestones, and how specific aims toward these milestones will be staged or integrated. Key decision points in the organizational/work flow chart and SOW should be clearly defined, and their impact on the overall project should be clear. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Related Documents
Folder 51452 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 51452 Full Announcement-1 -> bcrp_fy10 mta pa_gg.pdf
Folder 51452 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00016157 | Jan 29, 2010 | Jun 23, 2010 | View |
Package 1
Mandatory forms
51452 RR_SF424_1_2-1.2.pdf
51452 PerformanceSite_1_4-1.4.pdf
Optional forms
51452 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
